Fn-rLys-Col/SF-S healed skin defects one week earlier than the control group.
The biomimetic dressing demonstrated good water vapor balance and antibacterial properties.
In vitro tests indicated it is non-toxic to cells and promotes cell proliferation and migration.
The newly formed skin structure at 21 days closely resembled normal skin.
Immunohistochemistry and qRT-PCR results showed reduced inflammation and enhanced collagen deposition.
The dressing may promote angiogenesis and regulate the degree of fibrosis.
Simplified
PURPOSE: In cases of large-area skin defects, the absence of can lead to difficulties in fibroblast migration, thereby hindering wound healing. This study aimed to address the challenges in treating skin defects by developing a biomimetic nano-dressing that both has antibacterial properties and promotes healing by mimicking the extracellular matrix.
PATIENTS AND METHODS: The electrospun silk protein nanofibers were ultrasonically fragmented into staple fibers. These were then coated and modified by adding a collagen (Col) solution loaded with recombinant lysostaphin (rLys) and fibronectin (Fn), ultimately constructing a biomimetic nanosponge (Fn-rLys-Col/SF-S).
RESULTS: In vitro studies have shown that Fn-rLys-Col/SF-S possesses good water vapor balance and antibacterial properties, is non-toxic to cells, and can promote cell proliferation and migration. In vivo experimental results indicated that Fn-rLys-Col/SF-S healed a week earlier than the control group, with the structure of the newly formed skin resembling normal skin at 21 days. Further immunohistochemistry and qRT-PCR results demonstrated that Fn-rLys-Col/SF-S effectively promotes the healing of skin defect wounds by reducing inflammation, promoting angiogenesis, enhancing collagen deposition, and regulating the degree of fibrosis.
CONCLUSION: In conclusion, the Fn-rLys-Col/SF-S biomimetic sponge dressing can promote the repair of skin defects by mimicking the extracellular matrix, providing a potential therapeutic strategy for clinical wound treatment.
Key numbers
7 days
Healing Time Reduction
Fn-rLys-Col/SF-S dressing vs. control treatments
77.8±0.31%
Rate
Against MRSA
Full Text
We can’t show the full text here under this license.
